Comparison of methods for calculating rectal dose after (125)I prostate brachytherapy implants.
- 1 July 2002
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 53 (3) , 775-785
- https://doi.org/10.1016/s0360-3016(02)02798-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose–volume histogram analysisInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Rectal function following prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Rectal complications associated with transperineal interstitial brachytherapy for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysisInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64Medical Physics, 1999
- Rectal dosimetric analysis following prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Clinical Course of Rectal Bleeding Following I-125 Prostate BrachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Brachytherapy for clinically localized prostate cancer: Results at 7- and 8-year follow-upSeminars in Surgical Oncology, 1997
- Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995